Navigation

ExploreAnalysisInvestor RelationsAI AssistantCompareScreener
LoginSign Up FreeSign Up

© 2026 MarketCI. All rights reserved.

HelpPricingPrivacyTerms
ID

IDXX

Market Closed

IDEXX Laboratories, Inc.

NASDAQHealthcareMedical - Diagnostics & Research
US
11.00K employees
CEO: Michael Erickson
Founded: 1991
$708.50
+$0.00(+NaN%)
Market Cap
55.82B
Beta
1.54
52W Range
N/A
Dividend Yield
0.00%
OverviewForecastsFundamentalMarket SentimentValuationOwnership
OverviewForecastsFundamentalMarket SentimentValuationOwnership
Comprehensive Valuation
In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: IDEXX Laboratories trades 41% above its weighted fair value of $415.80, indicating potential overvaluation. Strong profitability and efficiency contrast with Monte Carlo estimates suggesting downside risk and valuation closer to $130-$160. High volatility and a 100% downside risk in scenarios highlight elevated investment risk.
Enhanced Football Field Analysis
Loading comprehensive valuation data...

Fetching multi-methodology valuation ranges...

Explore IDXX

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

IDXX in the Healthcare

Large Cap
Healthcare

Browse sector stocks →

Medical - Diagnostics & Research

Browse industry stocks →